Catalent's CEO Confirms Leadership Continuity As Novo Holdings Acquisition Nears
Express News | Catalent Inc - Alessandro Maselli to Remain President and CEO Post-Close
Express News | Catalent Issues Open Letter to Customers Regarding Pending Acquisition by Novo Holdings
Press Release: Catalent Issues Open Letter to Customers Regarding Pending Acquisition by Novo Holdings
European Equities Close Mostly Higher in Friday Trading; Novo Nordisk's Catalent Acquisition Faces Roadblock
Weight loss drug expansion plan faces obstacles! Consumer groups in the USA demand the FTC to block the shareholders of novo-nordisk a/s from acquiring catalent.
On Thursday, consumer groups and two large unions in the usa urged the Federal Trade Commission (FTC) to block the acquisition contract of drug manufacturer catalent by novo-nordisk a/s shareholder Novo Holdings.
Novo Nordisk-Catalent Deal Faces Opposition From Consumer Groups Over Competition Concerns
Consumer groups are requesting the FTC in the usa to block Novo Holdings' acquisition of catalent.
According to Reuters on October 18th, consumer groups and two major unions in the USA urged the Federal Trade Commission (FTC) to block the acquisition contract of drug manufacturer Catalent by Novo Nordisk A/S's shareholder Novo Holdings, stating that the deal threatens competition in the weight loss and cutting-edge genetic therapy areas. The Public Interest Research Group, Service Employees International Union (SEIU), and other organizations expressed concerns about this $16.5 billion deal in a letter to the FTC. Last week, Democratic Senator Warren also called on the FTC to closely monitor this transaction, citing similar reasons.
Consumer Groups Ask FTC to Block Novo Holdings-Catalent Deal
Catalent Stock Flat Following the Sell Agreement With Ardena
Jim Cramer: 'We Need More Uranium,' Recommends This Stock; Says Novo Nordisk 'Doesn't Hold A Candle' To Big Pharma Rival
Trump or Harris? Analysts are hotly debating the impact of the election results on various sectors of the US stock market.
①Over the past 8 years, the Trump administration and the Biden-Harris administration have fully demonstrated their policy orientations; ②Overall, industries such as finance and technology that are under the key regulation of the Biden administration are more likely to benefit from Trump's "rollback" policies, while the bullish outlook for other industries is relatively less obvious.
Express News | Catalent Inc - Financial Details of Agreement, Which Is Expected to Close in Early 2025, Have Not Been Disclosed
Catalent Signs Agreement to Sell Somerset, NJ Oral Solids Facility
Ardena Signs Agreement to Expand US Footprint With the Acquisition of Advanced Drug Product Manufacturing Facility From Catalent
Press Release: Catalent Signs Agreement to Sell Somerset, NJ Oral Solids Facility
Express News | Catalent Signs Agreement to Sell Somerset, Nj Oral Solids Facility
Sector Update: Health Care Stocks Retreat Thursday Afternoon
FTC Faces Pressure to Block Novo Nordisk-Catalent Merger Over Antitrust Fears
'Warren Urges FTC to Probe Deal That Would Give Novo Nordisk Control of Some Catalent Plants; At Issue Is Whether the Deal Would Give Novo an Unfair Advantage in the Market for Obesity, Diabetes Drugs' - STAT News